$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Market price analysis of pemigatinib as a targeted drug in treatment
2026-02-01 22:25:32
Check Details
Whether Erdafitinib is currently included in the national medical insurance and its actual reimbursement rate
2026-02-01 22:25:32
Check Details
Erlotinib (Loret) can be taken continuously for up to several years in clinical practice and its long-term safety analysis
2026-02-01 22:25:32
Check Details
Whether tofacitinib and tofacitinib citrate tablets are equivalent and the differences between different versions
2026-02-01 22:25:32
Check Details
Analysis of the key performance of cycloserine’s actual role and efficacy in clinical anti-infective treatment
2026-02-01 22:25:32
Check Details
Comprehensive explanation of common adverse reactions and monitoring key points of linezolid (Siwo) in clinical use
2026-02-01 22:25:32
Check Details
Is ribociclib (Kaillon) a chemotherapy drug or a targeted drug and its specific positioning in clinical treatment?
2026-02-01 22:25:32
Check Details
A comprehensive analysis of the indications, usage, dosage and safety information in the official instructions of Cemiplimab
2026-02-01 22:25:32
Check Details
Analysis of the core functions and clinical application value of Daprodustat in the treatment of anemia
2026-02-01 22:25:32
Check Details
The scope of approved indications for durvalumab (durvalumab) and its clinical application in different cancer types
2026-02-01 22:25:32
Check Details
Detailed analysis of usage, dosage and indications in the official instructions of Zolbetuximab
2026-02-01 22:25:32
Check Details
How many days can one bottle of EIKANCE 0.01% Atropine Sulfate Eye Drops be used and the dosage instructions for different age groups?
2026-02-01 22:25:32
Check Details
1
2
...
2403
2404
2405
2406
2407
2408
2409
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
2
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
3
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
4
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
5
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
6
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
7
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
8
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
9
Adagrasib Medication Management Guide for Special Populations
10
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
11
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
12
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment